53 results about "Menstrual cycle" patented technology

The invention provides an early pregnancy risk prediction method and system based on multi-source data and a medium. Firstly, basic information, physiological cycle data and living habit data of a user are collected through a preset interface; preprocessing the original data to generate standardized structure data; extracting age features, periodic regularity features and living habit features to obtain a feature vector set; then, sequentially comparing the age feature with a first threshold value to generate a risk index, comparing the physiological cycle feature with a second threshold value to update the risk index, and matching the living habit feature with a third threshold value to obtain feature matching information; integrating the risk index and the matching information based on a weighted fusion algorithm to generate a pregnancy risk score; and finally, generating a visual risk interface through a graphic rendering engine in combination with historical data, and outputting the visual risk interface. Therefore, comprehensive assessment and real-time monitoring of pregnancy risks are realized, and the accuracy of health management and the effectiveness of decision support are improved.

A method for determining for a female a time interval for using contraception is disclosed, the method comprising receiving in a processor (11), from a sensor system (22) of a wearable device (2) of the female, physiological data of the female, generating cycle phase probabilities of the female being in one or more cycle phases of her menstrual cycle on a given day, by use of a machine learning model and the physiological data, determining the time interval for using contraception using the physiological data, the cycle phase probabilities, and pre-determined cycle phase probability thresholds, and generating a message for the female comprising the time interval for using contraception.

An Artificial Intelligence (AI) system trained by a plurality of training data. The AI system is trained by relationships between a time to final menstrual period and ratios between follicle-stimulating hormone levels and estradiol levels, anti-mullerian hormone, race, cholesterol levels, and a presence of one or more contraceptives. The AI system is configured to accept data from only one sample from a user as input and generate a prediction of a time to final menstrual period for the user as output.

The invention discloses a traditional Chinese medicine gynecology dysmenorrhea patient treatment device, and relates to the technical field of traditional Chinese medicine gynecology, the technical scheme is characterized in that the traditional Chinese medicine gynecology dysmenorrhea patient treatment device comprises a connecting belt, a buckle is arranged at the end of the connecting belt, the other end of the connecting belt is clamped on the buckle, and the traditional Chinese medicine gynecology dysmenorrhea patient treatment device further comprises a massage module; the hot compress massage disc is arranged on the connecting belt, and a massage head is arranged on the hot compress massage disc; the data acquisition module is used for acquiring individual physiological data and dysmenorrhea symptom data of the traditional Chinese medicine gynecological dysmenorrhea patient; the data analysis module is used for analyzing according to the individual physiological data to obtain a first pre-selected hot compress parameter group of the hot compress massage disc and obtaining a first hot compress parameter set according to the first pre-selected hot compress parameter group; the device has the effects of dynamically capturing the change of the condition of a patient, updating a parameter scheme in real time along with the menstrual cycle and the treatment progress, adapting to the requirements of different stages such as the development stage and the remission stage, realizing accurate nursing in the whole process, and remarkably improving the treatment accuracy, adaptability and comprehensive curative effect.

The invention relates to the technical field of gynecological acupuncture and moxibustion, in particular to a traditional Chinese medicine acupoint stimulation device for gynecological menstrual cycle conditioning, which comprises a main body, an acupuncture needle, a needle clamp, an electric pulse driving module and a motor controller, the main body comprises a fixing structure, a motor stator, a motor rotor, a spring and a clamp fixing disc, and the fixing structure is mounted on the motor stator. A doctor only needs to search acupuncture points for acupuncture operation, after acupuncture is completed, other personnel operate the traditional Chinese medicine acupoint stimulation device, installation of the traditional Chinese medicine acupoint stimulation device is completed, twisting and lifting operation procedures are set for each acupuncture point in advance, twisting and lifting are automatically completed during remaining of acupuncture needles, work of the doctor is relieved, and the work efficiency of the doctor is improved. A doctor can have more time to treat other patients, and the treatment efficiency is improved.

The invention relates to an acupuncture-assisted acupoint selection device for adjusting a menstrual cycle in the field of acupoint selection devices. The acupuncture-assisted acupoint selection device comprises a system end and an equipment end, the equipment end comprises a wearable data collector and a stimulation device, and the system end comprises a data collection module, a data storage module and an acupoint selection module; the data acquisition module is used for acquiring physiological data and treatment feedback data; the data storage module is used for storing structured data, and the acupoint selection module is used for selecting acupoint combinations and stimulation schemes according to physiological data and treatment feedback data; the stimulation device comprises a control terminal with a display unit and a plurality of stimulation sheets with numbers; the stimulation piece comprises a base surface layer, a sub-control unit is fixedly connected to the base surface layer, an outer bonding layer and a stimulation unit are fixedly connected to the lower end of the base surface layer, real-time monitoring of the physiological state of a user is achieved through accurate data collection and analysis, and the accuracy and individuation level of physiotherapy are easily improved through an intelligent acupoint selection and stimulation scheme.

The objective is to provide a health management system, toilet seat device, and toilet device that are easy to implement. [Solution] A health management system is provided comprising: an excrement detection unit that detects feces in a toilet; a processing unit that makes a determination about the user's feces based on the data acquired by the excrement detection unit; and a notification unit, wherein the processing unit estimates information about the user's menstrual cycle based on the data acquired by the excrement detection unit, and the notification unit provides notification based on the information about the user's menstrual cycle estimated by the processing unit.

The composition and / or combinations includes diosgenin and at least one other agent selected from vitamin D and α-lactalbumin and its use in the regularization of the menstrual cycle and in the reduction of ovarian cysts, in particular in women affected with polycystic ovarian syndrome (PCOS) phenotype D.

: A technique for estimating whether or not a subject has an infection from their physiology that is capable of adjusting for menstrual cycle states. The technique comprises obtaining physiological data representing one or more of the subject's physiological parameters at a first point in time, such as skin temperature and resting heart rate. The physiological data is then used to estimate the subject's menstrual state at the first point in time. In particular, the subject's menstrual state is known to impact their physiology. Both the physiological data and the estimated menstrual state are then subsequently used to estimate the subject's infection state. Specifically, the physiological data and the menstrual state are processed using a machine-learning model.

The present invention relates to the technical field of diapers, specifically a diaper suitable for use during menstruation. The diaper comprises, from top to bottom, a porous permeable layer, an intermediate layer, and a breathable base film layer; the intermediate layer comprises an upper layer, a composite core, and a lower layer; and the composite core comprises a deodorizing and antibacterial hydrogel freeze-dried material. The present invention can effectively decompose blood and blood clots, reduce menstrual blood viscosity, accelerate the downward permeation rate of menstrual blood, and thereby promote its absorption. The deodorizing and antibacterial hydrogel freeze-dried material enhances water absorption, breathability, antibacterial properties, and deodorizing properties, thereby improving the comfort of the diaper, eliminating the feeling of stuffiness and dampness, and effectively meeting the care requirements for women facing incontinence during their menstrual cycle.

The invention discloses a traditional Chinese medicine composition for treating infertility. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: red ginseng, pseudo-ginseng, fructus corni, fructus lycii, angelica sinensis, Chinese yam, poria cocos, dragon's blood, ligusticum wallichii, carthamus tinctorius, teasel root, fructus alpiniae oxyphyllae, radix cyathulae, pawpaw, cynomorium songaricum, fleece-flower root, wild gastrodia elata, combined spicebush root, hippocampus, cinnamon, semen cuscutae, eucommia ulmoides, glossy privet fruit, fenugreek, tribulus terrestris, lycium ruthenicum and native copper. , fructus rosae laevigatae and magnetite. Compared with similar medicines in the market, the traditional Chinese medicine composition can effectively improve related indexes of reproduction of patients, increase the thickness of endometrium, promote follicular development, adjust the menstrual cycle and improve the semen quality, so that the pregnancy condition is improved.

Techniques for data analysis and user guidance are provided for determining and providing one or more therapies to a user based on where the user is or will be in their menstrual cycle. In certain embodiments, a method of personalizing diabetes therapy based on information related to a user's menstrual cycle is provided. The method includes measuring blood glucose measurements of the user using a glucose monitoring system. The method also includes receiving information related to the user's menstrual cycle. The method further includes determining a therapy for the user to achieve a target blood glucose during a sub-phase or phase of the user's menstrual cycle based on at least one of historical data associated with the user and historical data associated with a stratified group.

The application discloses a preparation method of a 3D model of a maternal-fetal interface constructed by an endometrial organoid in vitro, and the method comprises the following steps: establishing a primary endometrial epithelial organoid and an endometrial stromal cell line in vitro; improving an extracellular matrix for assembling endometrial gland-like organoids and stromal cells; the constructed endometrial organoid model comprises gland cells and stromal cells; the endometrial organoid model is cultured by using a gas-liquid interface, so that the endometrial organoid model has a cavity epithelium and a gland structure; the endometrial organoid model simulates a menstrual cycle of the endometrium and performs function identification. The endometrial organoid model has the cavity epithelium and the gland epithelium for the first time, the tissue structure, the cell composition, the hormone-induced change, the gene expression characteristics of the organoid are similar to those in the body, and the organoid can reproduce the receptivity genes and the dynamicity of cilia which are necessary for embryo implantation in the body; the organoid can be used as a model for studying embryo implantation regulation, endometrial diseases and regeneration mechanisms.

A series of electrodes and a machine learning system are configured to detect changes in biological tissue over time. Specifically, the system may include a wearable device configured to detect changes in tissue response to an electrical signal that may be indicative of cancerous tissue, e.g., breast cancer and / or other types of cancer. The system optionally combines measurements from bioimpedance sensors, miniaturized ultrasound arrays, temperature sensors, and / or printed microwave planar antenna to detect changes in breast tissue composition and vascularity. The system may also be used to detect other physiological states such as menstrual cycles and / or various conditions related to hydration or breathing patterns.

[Technical Problem] Previously, it was not possible to predict menstrual-related information using abdominal sounds. [Technical Means] A menstrual-related information output device comprising a learning information storage unit, a sound information acquisition unit, a prediction unit, and an output unit can predict menstrual-related information using abdominal sounds from the abdomen. The learning information storage unit stores learning information consisting of two or more teaching data points, including sound information acquired from the user's abdominal sounds and menstrual-related information related to menstruation. The sound information acquisition unit acquires sound information from the user's abdominal sounds. The prediction unit applies the learning information to the sound information acquired by the sound information acquisition unit and acquires menstrual-related information. The output unit outputs the menstrual-related information acquired by the prediction unit.

The present invention relates to methods of treatment of menstrual cycle induced disorders and symptoms with cathinone, particularly methods employing 3-methyl methcathinone (3-MMC). The present invention also relates to kits comprising 3-MMC for use in the treatment of subjects suffering from menstrual cycle induced disorders and symptoms. In particular, methods and kits for therapy of menstrual cycle induced disorders and symptoms with 3-MMC for a variety of disorders and / or conditions, including PMS, PMDD and perimenstrual disorders are provided.

The invention relates to the technical field of gynaecology and obstetrics, in particular to a comprehensive treatment method for polycystic ovarian syndrome in gynaecology and obstetrics. Step 2, comprehensive treatment; step 3, performing subsequent feedback; according to the system, close cooperation of various modes such as lifestyle adjustment, drug treatment and surgical treatment is achieved, a patient can learn about specific conditions such as the weight, the menstrual cycle and the blood sugar level of the patient through professional self-management guidance, and the patient can timely and accurately feed back various conditions in the treatment process to a doctor; problems possibly existing in the treatment process can be found in time, the treatment scheme is adjusted in a targeted mode, and better and more effective treatment experience is provided for patients with the polycystic ovarian syndrome.

Provided are systems for grouping users who have chosen to participate into one of a plurality of menstrual cycle groups based on data provided by and / or collected from those users. In some examples, a wearable computing device can include one or more sensors that can measure one or more physiological signals associated with the user. Based on the physiological signals gathered from the one or more sensors, the wearable computing device can determine biometric data for one or more users. Furthermore, the wearable computing device can enable a user to submit information about their menstrual cycle (e.g., via an interactive touch screen). These factors can be used to automatically determine some menstrual cycle data for a user.

Embodiments are directed to systems and techniques for tracking menstrual cycles, which can include receiving temperature measurements from an array of temperature sensors positioned on a bed. A use period for the array can be determined when temperature measurements from at least one temperature sensor of the one or more temperature sensors exceed a first temperature threshold. In some embodiments, for each use period in a set of two or more use periods, a temperature of the user using the set of temperatures from the respective use period can be determined. After determining the temperature of the user for each use period in the set of two or more use periods, at least one change in the temperature of the user between different use periods can be identified. An ovulation day of the user based on the at least one change in the temperature of the user can be estimated.

According to some exemplary embodiments of the present disclosure, disclosed is a method for providing menstrual related information, which is performed by a computing device. The method may include: obtaining biometric information including a plurality of predetermined electrocardiogram variable information, the plurality of electrocardiogram variable information including time series data; obtaining user question and answer information corresponding to the plurality of electrocardiogram variable information; and generating, by an analysis model, menstrual cycle prediction information based on the biometric information and the user question and answer information.

The invention relates to a test cartridge for use in an analysis unit for hormone measurement, comprising at least one insertion opening for receiving a sample to be measured, in particular saliva, urine, or blood, and at least one reagent reservoir, wherein reaction reagents, in particular comprising at least one buffer medium, are stored in the at least one reagent reservoir, further comprising measuring chambers, wherein in each measuring chamber, preferably exclusively for one menstrual cycle hormone, detection reagents for the quantitative and / or qualitative detection of menstrual cycle hormones are stored, and at least one fluid path, wherein the fluid path is configured as a connection between the insertion opening and the measuring chambers and / or the reagent reservoir and the measuring chambers, wherein measuring chambers with detection reagents for three, in particular at least five, menstrual cycle hormones,preferably including at least progesterone and / or estrogen and / or follicle-stimulating hormone and / or luteinizing hormone and / or human chorionic gonadotropin.

A series of electrodes and a machine learning system are configured to detect changes in biological tissue over time. Specifically, the system may include a wearable device configured to detect changes in tissue response to an electrical signal that may be indicative of cancerous tissue, e.g., breast cancer and / or other types of cancer. The system optionally combines measurements from bioimpedance sensors, miniaturized ultrasound arrays, temperature sensors, and / or printed microwave planar antenna to detect changes in breast tissue composition and vascularity. The system may also be used to detect other physiological states such as menstrual cycles and / or various conditions related to hydration or breathing patterns.

The invention discloses a herbal formula with the effects of regulating menstruation, relieving pain, warming ovary, warming uterus and dredging qi and blood, and particularly relates to the technical field of traditional Chinese medicine conditioning, and the herbal formula comprises special decoction prescriptions for the premenstrual period, the menstruation period and the post-menstrual period and corresponding preparation processes of the decoction prescriptions. The traditional Chinese medicine composition comprises the following components by weight: 5-7g of loofah sponge, 4-6g of liquidambar formosana hance, 5-7g of rose, 7-9g of fried hawthorn, 4-6g of pericarpium citri reticulatae, 9-11g of poria cocos and 20-30g of red dates. The formula strictly adapts to the physiological characteristics and common discomfort of the menstrual cycle including the premenstrual period, the menstrual period and the post-menstrual period, staged precise intervention is achieved, the limitation of a single soup formula is broken through, meanwhile, dual repair of ovary maintenance and qi and blood nourishing is achieved, and the curative effect is good. Periodic conditioning can effectively relieve common menstrual period problems such as premenstrual swelling pain, menstrual period abdominal pain and latter menstrual period weakness, and long-term use of the traditional Chinese medicine is helpful for improving the menstrual cycle rule, so that female reproductive health is maintained from the source.

An Artificial Intelligence (AI) system trained by a plurality of training data. The AI system is trained by relationships between a time to final menstrual period and ratios between follicle-stimulating hormone levels and estradiol levels, race, cholesterol levels, and a presence of one or more contraceptives. The AI system is configured to accept data from only one sample from a user as input and generate a prediction of a time to final menstrual period for the user as output.

This invention relates to a method and system for detecting ovulation in female's menstrual cycles, which involves collecting menstrual cycle information of a subject to calculate ovulation interval dates. Daily heart rate waveform signals are used to obtain heart rate-related physiological parameters, including the first cumulative power (LF), second cumulative power (HF), standard deviation of interbeat intervals (SDNN), root mean square of successive differences (RMSSD), cumulative power ratio (LF / HF), and heart rate parameter ratio (SDNN / RMSSD). The invention selects the day with the highest cumulative power ratio (LF / HF) and heart rate parameter ratio (SDNN / RMSSD) within the ovulation interval as the day of ovulation.

The invention belongs to the technical field of medical treatment, and particularly relates to a safe intrauterine adhesion prevention support and a use method thereof. The stent is composed of hydrogel and sterilized water for injection, the hydrogel is of a hollow spiral inverted pear-shaped structure, the hydrogel expands to be balanced after meeting the sterilized water for injection to form the stent, the shape of the stent is matched with the uterine cavity, and the stent is completely attached to the inner wall of the uterine cavity; the dosage of the sterilized water for injection is calculated according to a formula V = min (L / l, W / w1, T / t) * v. Based on the physiological structure and physiological movement of the uterus, the support absorbs water and expands after passing through the cervix so as to expand the inner wall of the uterus, the support is broken into small particles through physiological pressure generated by endometrial peristalsis, and the small particles and menstrual blood are discharged out of the body together. According to the intrauterine device, adhesion is effectively prevented in the uterine cavity, meanwhile, the risks of uterine infection and overlarge pressure cannot be caused, the intrauterine device is not affected by the individual size of the uterus and the menstrual cycle of the uterus, and the safety of the intrauterine device is improved.

In many societies, conversations around reproductive health remain silent, yet the fear of unwanted pregnancy continues to burden countless couples The present invention introduces a discreet, natural, and scientifically informed mobile-based calculating application system that empowers users to manage fertility confidently. By simply entering the start and end dates of a woman's menstrual cycle period, the application calculates and displays precise safe sex days—when the risk of conception is minimal—and also highlights fertile days with high chances of pregnancy. This innovative method allows couples to make informed decisions about intimacy, either to prevent pregnancy or to plan pregnancy, all without pills, devices, or medical intervention. The system eliminates guesswork, offering clarity, privacy, and control over one's reproductive choices. With no side effects, this method ensures a stress-free, long-term solution for birth spacing and natural contraception. It redefines personal health management—transforming fear and confusion into confidence and control through simple, smart technology through mobile calculating application. For the next month accessing & calculating menstrual cycle window days & dates by input the present menstrual cycle starts & complete dates in mobile calculating application table finding out about real menstrual cycle window, on our choice of avoid or conception pregnancy.

The paper provides samples, a system for collecting samples, and a method for preserving samples from menstrual fluid.

The present invention relates to compositions and / or combinations comprising diosgenin and at least one further agent selected from vitamin D and alpha-lactalbumin and their use in modulating menstrual cycle and reducing ovarian cyst, in particular in women affected by Polycystic Ovarian Syndrome (PCOS) phenotype D.

The application belongs to the field of medicine, and particularly relates to a traditional Chinese medicine Lijia composition for regulating oligomenorrhea, a preparation method and application thereof. The traditional Chinese medicine Lijia composition is combined according to the basic theory of monarch, minister, assistant and guide, and the medicinal property characteristics of Lijia, and can jointly play the effects of drying dampness, promoting blood circulation to remove blood stasis, invigorating the spleen and tonifying the kidney, and regulating the Chong and Ren meridians. After the patient takes the composition, the menstrual cycle can be prolonged, the PBAC score can be increased, the serum FSH and LH levels can be significantly reduced, the estradiol and progesterone can be significantly increased, and the oligomenorrhea symptoms of the patient can be significantly improved.